Jamie Lopez Bernal

Jamie Lopez Bernal publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jamie Lopez Bernal sits on this spectrum.

Jamie Lopez Bernal D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jamie Lopez Bernal sits on this spectrum.

Best Publications

• Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

  Jamielopez L. Bernal;Nick Andrews;Charlotte Gower;Eileen Gallagher

  2593
  Citations

• Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.

  James Lopez Bernal;James Lopez Bernal;James Lopez Bernal;Nicholas Andrews;Nicholas Andrews;Charlotte Gower;Chris Robertson

  1374
  Citations

• Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.

  Unknown

  1226
  Citations

• Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020.

  Anika Singanayagam;Monika Patel;Andre Charlett;Jamie Lopez Bernal

  968
  Citations

• COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.

  Victoria Jane Hall;Victoria Jane Hall;Sarah Foulkes;Ayoub Saei;Nick Andrews;Nick Andrews

  743
  Citations

• SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).

  V J Hall;S Foulkes;A Charlett;A Atti

  690
  Citations

• Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.

  Simon de Lusignan;Simon de Lusignan;Jienchi Dorward;Jienchi Dorward;Ana Correa;Ana Correa;Nicholas Jones

  643
  Citations

• Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

  Unknown

  545
  Citations

• SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England.

  Sharif A Ismail;Sharif A Ismail;Vanessa Saliba;Jamie Lopez Bernal;Mary E Ramsay

  344
  Citations

• Effectiveness of COVID-19 vaccines against the B.1.617.2 variant

  Jamie Lopez Bernal;Jamie Lopez Bernal;Jamie Lopez Bernal;Nick Andrews;Nick Andrews;Charlotte Gower;Eileen Gallagher

  342
  Citations

• Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack

  Jamie Lopez;Jamie Lopez;Olivia Susanto;Misty Jenkins;Misty Jenkins;Natalya Lukoyanova

  322
  Citations

• Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time

  Misty R. Jenkins;Jesse A. Rudd-Schmidt;Jamie A. Lopez;Jamie A. Lopez;Kelly M. Ramsbottom;Kelly M. Ramsbottom

  277
  Citations

• Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups

  Unknown

  257
  Citations

• Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England

  Jamie Lopez Bernal;Jamie Lopez Bernal;Jamie Lopez Bernal;Nick Andrews;Nick Andrews;Charlotte Gower;Julia Stowe

  226
  Citations

• Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study

  Unknown

  223
  Citations

• Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design.

  Julia Stowe;Elise Tessier;Hongxin Zhao;Rebecca Guy

  194
  Citations

• Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern

  Unknown

  192
  Citations

• Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

  Unknown

  191
  Citations

• Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.

  Madhumita Shrotri;Maria Krutikov;Tom Palmer;Rebecca Giddings

  179
  Citations

• COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England

  Unknown

  173
  Citations